BeStock  
Stocks › Drug Manufacturers - Specialty & Generic › EOLS

Evolus EOLS

US equityMarket cap rank #3732Drug Manufacturers - Specialty & Generic
$7.67 −$0.07 (-0.92%)
Market open · Oct 8, 10:00 am ET · After hours $7.74 0.00%
Open$7.68
Prev close$7.74
Day range$7.55 – $7.68
Volume33.2K
Market cap$506.54M
P/E (TTM)–
Dividend yield–

EOLS Stock News

Headlines matching Evolus or the EOLS ticker, most recent first.

  • Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)TipRanks · 17 Sep 2026 · Direct mention
  • Leerink Partners Maintains Evolus(EOLS.US) With Buy RatingMarket news · 17 Sep 2026 · Direct mention
  • Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $15Market news · 11 Sep 2026 · Direct mention
  • BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13Market news · 7 Aug 2026 · Direct mention
  • Needham Maintains Evolus(EOLS.US) With Hold RatingMarket news · 7 Aug 2026 · Direct mention
  • Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17Market news · 6 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $17Market news · 6 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13Market news · 25 Aug 2026 · Direct mention
  • Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS) PositiveTipRanks · 5 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $15Market news · 4 Mar 2026 · Direct mention
  • Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $15 NegativeMarket news · 4 Feb 2026 · Direct mention
  • Analysts Are Bullish on These Healthcare Stocks: Evolus (EOLS), Upstream Bio, Inc. (UPB) PositiveTipRanks · 4 Feb 2026 · Direct mention
  • BTIG Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $13 NegativeMarket news · 22 Jan 2026 · Direct mention
  • Stifel Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $17 NegativeMarket news · 13 Jan 2026 · Direct mention
  • Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $19Market news · 10 Jan 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on EOLS.

Leave a comment

Scroll to Top